
<table style="text-align:center"><caption><strong>Poisson Models of Market Authorizations for NEW Orphan Drugs (Not adjusted for Error Structure)</strong></caption>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="6"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="6" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="6">Annual Number of Market Authorizations for NEW Orphan Drugs</td></tr>
<tr><td style="text-align:left"></td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td><td>(6)</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD)</td><td></td><td></td><td>-0.005</td><td>0.014</td><td>-0.004</td><td>0.019</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.008)</td><td>(0.043)</td><td>(0.008)</td><td>(0.044)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">US</td><td>0.899<sup>***</sup></td><td>0.659<sup>***</sup></td><td>0.688<sup>***</sup></td><td>0.966</td><td>0.687<sup>***</sup></td><td>1.033</td></tr>
<tr><td style="text-align:left"></td><td>(0.086)</td><td>(0.195)</td><td>(0.202)</td><td>(0.676)</td><td>(0.202)</td><td>(0.682)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004</td><td>0.076<sup>***</sup></td><td>0.060<sup>***</sup></td><td>0.065<sup>***</sup></td><td>0.043</td><td>0.064<sup>***</sup></td><td>0.036</td></tr>
<tr><td style="text-align:left"></td><td>(0.008)</td><td>(0.014)</td><td>(0.017)</td><td>(0.055)</td><td>(0.018)</td><td>(0.056)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate Per Capita</td><td></td><td></td><td></td><td></td><td>-1.489</td><td>-1.577</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td>(1.582)</td><td>(1.588)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US</td><td></td><td>0.023</td><td>0.031</td><td>0.056</td><td>0.030</td><td>0.061</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.017)</td><td>(0.022)</td><td>(0.061)</td><td>(0.022)</td><td>(0.062)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US</td><td></td><td></td><td></td><td>-0.019</td><td></td><td>-0.024</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.044)</td><td></td><td>(0.044)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept</td><td>1.646<sup>***</sup></td><td>1.814<sup>***</sup></td><td>1.881<sup>***</sup></td><td>1.617<sup>**</sup></td><td>1.887<sup>***</sup></td><td>1.559<sup>**</sup></td></tr>
<tr><td style="text-align:left"></td><td>(0.109)</td><td>(0.161)</td><td>(0.199)</td><td>(0.645)</td><td>(0.200)</td><td>(0.650)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Observations</td><td>36</td><td>36</td><td>36</td><td>36</td><td>36</td><td>36</td></tr>
<tr><td style="text-align:left">Log Likelihood</td><td>-105.688</td><td>-104.775</td><td>-104.607</td><td>-104.514</td><td>-104.170</td><td>-104.028</td></tr>
<tr><td style="text-align:left">Akaike Inf. Crit.</td><td>217.376</td><td>217.550</td><td>219.215</td><td>221.028</td><td>220.341</td><td>222.056</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="6" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
